The short version of chain of custody fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-08-01. Anything still debated is marked as such rather than presented as settled.
Tirzepatide is a synthetic peptide built from 39 amino acid residues. Its backbone derives from the native glucose-dependent insulinotropic polypeptide sequence, altered at several positions to resist enzymatic cleavage. A fatty diacid group attached through a linker extends plasma residence time by promoting reversible binding to serum albumin. The molecule carries a net negative charge near physiological pH and has a reported molecular weight close to 4813 daltons. These features separate it from shorter incretin analogs and account for its prolonged dosing interval.
Pharmacologically, tirzepatide activates two distinct G protein-coupled receptors: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor. Binding at each target triggers cyclic AMP accumulation and downstream signaling in pancreatic beta cells, adipose tissue and the central nervous system. Because the two pathways overlap only partially, the combined effect on insulin secretion, glucagon suppression and appetite signaling differs from that of selective single-receptor compounds. Affinity is not equal across the two targets, and the clinical meaning of that imbalance remains an area of active study.
The peptide shares degradation routes common to modified peptides: deamidation of asparagine and glutamine residues, oxidation of methionine, and backbone hydrolysis under extreme pH. Lyophilized material is generally more stable than a solution, and residual water content directly affects the rate of hydrolysis. In liquid form, aggregation and visible particles can appear after agitation or repeated freeze-thaw cycles. Stability studies therefore track monomer content, aggregate content, and potency over months under defined temperature and humidity.
Cold-chain handling is standard for formulated product, with dry powder stored frozen and ready-to-use solutions refrigerated. Light exposure is minimized because photodegradation of certain amino acid side chains is possible. Shipping and temperature-excursion studies are used to establish whether short deviations affect quality attributes. Documentation supplied with research material usually includes a certificate of analysis listing purity, identity confirmation, and water or residual solvent content. Users are expected to confirm that material meets the stated specification before use.
Identity and purity of tirzepatide are assessed mainly by reversed-phase high-performance liquid chromatography with ultraviolet detection, often paired with mass spectrometry. Because the molecule carries several modifications, gradient conditions are adjusted to resolve the intact peptide from deamidation and oxidation products. Enzymatic digestion followed by peptide mapping confirms the primary sequence and locates specific modifications. Quantitation in biological matrices typically uses liquid chromatography with tandem mass spectrometry after solid-phase extraction. Immunoassays are used less often, since antibody cross-reactivity with closely related peptides can bias results.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Includes the 39-residue backbone and the attached fatty diacid |
| Molecular weight | Approximately 4813 Da | Average mass; the monoisotopic value is slightly lower |
| Receptor targets | GIP receptor and GLP-1 receptor | Dual engagement defines the pharmacological class |
| Backbone length | 39 amino acids | Sequence modified from native glucose-dependent insulinotropic polypeptide |
| Albumin interaction | Reversible, mediated by the fatty diacid | Slows renal clearance and lengthens circulation time |
Bulk peptide material is normally characterised by reversed-phase high-performance liquid chromatography, which separates the target sequence from truncation products and other closely related impurities. Ultraviolet detection near 214 nanometres is common because the peptide backbone absorbs in that region. Mass spectrometry, usually electrospray ionisation coupled to a mass analyser, is used to confirm the molecular mass. Because the molecule carries a lipophilic side chain, gradient methods often need a relatively high organic modifier fraction to elute it within a practical retention window.
Like most synthetic peptides of this size, the material is commonly supplied as a lyophilised powder that appears white to off-white. It dissolves in aqueous buffers and in mixtures of water with a small proportion of organic solvent, though the fatty acid portion reduces solubility in pure water relative to short peptides. Hygroscopic behaviour is reported for many peptide powders, so weighing is usually performed quickly and under controlled humidity. Working solutions are typically prepared fresh and kept cold.
Long-term storage of lyophilised peptide powder is generally at minus twenty degrees Celsius or colder, with desiccant and protection from light. Short-term storage at two to eight degrees Celsius is common during active use. In solution, stability depends strongly on pH, concentration, and the presence of preservatives, and hydrolysis or aggregation can develop over weeks. Published stability data specific to this molecule are limited, so recommended conditions for research material are usually extrapolated from general peptide handling practice rather than from a dedicated study.
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
定量分析的主流方法是反相高效液相色谱联用紫外或质谱检测，利用肽在疏水固定相上的保留行为确定纯度与含量。对于生物基质中的浓度测定，常采用液相色谱串联质谱，并配合固相萃取或蛋白沉淀进行样品前处理。免疫分析法也可使用，但可能受到结构相关肽的交叉反应干扰。
Research and analytical settings increasingly require documentation of peptide origin and chain of custody. Certificate of analysis documents typically report purity by chromatographic area, mass confirmation, appearance, and residual solvent or counterion content. Independent verification by an accredited laboratory is common when a material will be used in a regulated study. Open questions remain about how well compendial methods transfer between laboratories, and about which impurity thresholds are meaningful for materials not intended for clinical use.
Peptide-based pharmaceutical products such as tirzepatide require controlled temperature management to preserve structural integrity. Manufacturer labeling generally specifies refrigeration at 2 to 8 degrees Celsius before first use, with protection from light and freezing. Exposure to repeated temperature cycling can promote aggregation or deamidation, which alters the analytical profile even when the visible solution appears unchanged. Once a product is in use, the permitted storage window and temperature range are defined by the specific labeled presentation rather than by general peptide rules.
Identity and purity assessment of tirzepatide relies primarily on reversed-phase high-performance liquid chromatography coupled with ultraviolet detection. Mass spectrometry, often in electrospray ionization mode, confirms the molecular mass and detects sequence-related impurities. Peptide mapping after enzymatic digestion provides residue-level confirmation of the backbone. Each method addresses a different question: chromatography for purity and related substances, mass measurement for identity, and mapping for sequence fidelity. No single technique covers all three.
Both receptors are class B G protein-coupled receptors that signal largely through Gs-mediated cyclic AMP production. Activation within pancreatic islets increases glucose-dependent insulin secretion and suppresses glucagon release when glucose is elevated. Outside the pancreas, signaling in the central nervous system and gut appears to influence appetite and gastric emptying. The relative contribution of each receptor to observed clinical effects remains under investigation, and the two pathways are not simply additive in practice.
Reported outcomes in large trials include dose-dependent weight reduction and improvements in glycemic markers over periods ranging from several months to more than a year. Whether the compound alters long-term cardiovascular or renal outcomes is being examined in dedicated outcome studies, so those questions remain open. Labeling describes gastrointestinal effects such as nausea and diarrhea, which tend to appear during dose escalation. Discontinuation rates and the durability of effects after treatment stops vary across study populations and are still debated.
Growth over the corneal centre. Reduced vision due to corneal distortion. Documented growth. Symptoms of discomfort. Cosmesis. Surgery is usually performed under local anaesthetic with light sedation as day surgery. The pterygium is stripped carefully off the surface of the eye. If this is all that is done, the pterygium regrows frequently. The technique with the lowest recurrence rate uses an autotransplantation of conjunctiva from under the eyelid. This is placed over the defect remaining from the removed pterygium. The graft can be stitched in place, which is time-consuming, and painful for the patient afterwards. An alternative is the use of tissue adhesive fibrin glue. A Cochrane review including 14 studies and last updated October 2016, found that using fibrin glue when doing conjunctival autografting was associated with a reduced likelihood of the pterygium recurring compared with sutures. The review found that operations may take less time but fibrin glue may be associated with more complications (for example, rupture, shrinking, inflammation, granuloma). A 3-year clinical study on the application of collagen matrix as excision site grafts showed significantly improved surgery success rates. The mechanism of the collagen matrix graft (commercially available as ologen) works by promoting healthy cell growth into the matrix, thus preventing conjunctiva overgrowth that can cover the iris.
Amitriptyline is ineffective for HIV-associated neuropathy. In multiple sclerosis, it is frequently used to treat painful paresthesias in the arms and legs (e.g., burning sensations, pins and needles, stabbing pains) caused by damage to the pain-regulating pathways of the brain and spinal cord.
== Host/implant interactions == Wound healing of the skin and tendons is a complex coordinated process in the body that happens slowly over weeks or even years. A number of products in the market today aim to affect this process positively, although little data is available on their success. The majority of products are still in the development phases where the (often inflammatory) interactions between the host and the implanted devices are being assessed. Implanted ECM biomaterials fall into two general categories based on how they interact with the host. Incorporating devices eventually allow the growth of cells and passage of blood vessels through the matrix, whereas nonincorporating biomaterials are encapsulated by a wall of fused macrophages. In nonincorporating biomaterials such as Permacol, an acellular porcine dermal implant for hernia repair, it is important that the material is not degraded or infiltrated by the immune system. Encapsulated biomaterials that are recognized as foreign can be degraded and/or rejected by the body and migrate to the outside of the body. In incorporated ECM biomaterials, infiltration by the immune system can occur in as few as seven days, leading to rapid degradation of the device volume. In the case of Graftjacket, an allograft from human dermis, the matrix is quickly populated by host cells as vasculature. The device itself decreased more than 60% in volume, and is replaced with host fibroblasts and macrophages.
The prefect of Puno, Benito Laso de la Vega, tried to convince his colleagues in Lampa, Agustín Gamarra from Cuzco and Antonio Gutiérrez de la Fuente from Arequipa, of a project of "microfederalism" or "provincial federation" to separate the south and force the whole country to join the Andean federation of Bolívar. Santa Cruz did everything he could to prevent greater autonomy in the regions and persecute any separatist movement. He removed Laso from his duties and warned the other two. Later, during the Gran Colombian-Peruvian War, Sucre's anti-Peruvian attitudes were denounced, who, to commemorate the triumph of the Gran Columbian army over the Peruvian advance, ordered the construction of a commemorative obelisk on the site where the battle occurred, with an inscription increasing the number of Peruvian soldiers that took part in action and decreasing their own, in the following terms: "The Peruvian army of 8,000 soldiers that invaded the land of their liberators, was defeated by 4,000 braves from Colombia on February 27, 1829." José de la Mar protested the words on the monument, which he considered triumphalist and erroneous. In addition, he complained about the treatment received by the Peruvian dead and prisoners after the battle, with emphasis on the decapitation of the corpse of Pedro Raulet, one of the officers who fell in Tarqui, whose head was nailed to a pike and paraded through the streets of Cuenca.
Sources: en.wikipedia.org
American Association for the Advancement of Science American Chemical Society American Society for Biochemistry and Molecular Biology Endocrine Society National Academy of Sciences Sigma XI Swiss Chemical Society Hofmann was recognized with the following awards:
== Drug testing == Detectable levels of propoxyphene/dextropropoxyphene may stay in a person's system for up to 9 days after last dose and can be tested for specifically in nonstandard urinalysis, but may remain in the body longer in minuscule amounts. Propoxyphene does not show up on standard opiate/opioid tests because it is not chemically related to opiates as part of the OPI or OPI 2000 panels, which detect morphine and related compounds. It is most closely related to methadone.
Regorafenib (marketed under the trade name Stivarga) is currently being studied as a potential treatment option in multiple tumor types. On September 27, 2012, the FDA approved regorafenib for the treatment of patients with metastatic colorectal cancer who have been previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if KRAS wild-type, an anti-EGFR therapy. On February 25, 2013, the FDA approved regorafenib in a second indication to treat patients with locally advanced, unresectable or metastatic gastrointestinal stromal tumor (GIST) who have been previously treated with imatinib mesylate and sunitinib malate. Regorafenib is a compound developed by Bayer. The most common adverse reactions (≥ 20%) are asthenia/fatigue, hand-foot skin reaction (HFSR), diarrhea, decreased appetite/food intake, hypertension, mucositis, dysphonia and infection, pain (not otherwise specified), weight loss, abdominal pain, rash, fever and nausea. In 2011, Bayer entered into an agreement with Onyx under which Onyx will receive a 20 percent royalty on any future global net sales of regorafenib in oncology. Bayer and Onyx jointly promote Stivarga in the United States.
Sources: en.wikipedia.org
Strict breeding and farm management to reduce Salmonella prevalence in hens. Washing and sterilizing eggs at GP Centers (Grading and Packing facilities), often using hypochlorous acid solutions, before packaging. A best-before date system based on the assumption of raw consumption. Most producers set this date at about two weeks from packing, after which eggs are still considered safe if cooked thoroughly. A cold chain distribution system maintaining low temperatures from farm to retailer. Despite these measures, the risk is not zero. Salmonella can contaminate eggs externally via feces or internally if the hen itself is infected. Consumers are advised not to use cracked eggs for raw consumption.
Suitable computer and biological viruses already exist in the Pico Vault, an ultrasecure storage on the Moon, used for the most dangerous agents of these kinds. The Europa team also agree to leave a petabyte-capacity holographic 3D storage medium on Europa to allow Halman and other lifeforms in the monolith to upload themselves and escape the monolith's failure. The monolith does receive orders to exterminate humanity, and starts a duplication, whereupon millions of monoliths form two cascade screens to prevent Solar light and heat from reaching Earth and its colonies, but the monoliths all quickly disintegrate as a result of the virus. The monoliths' makers' response to its destruction will occur in another 900 years as the earliest possibility. The petabyte storage device, containing Halman and other lifeforms, but also infected with the virus, is subsequently sealed by scientists in the Pico Vault. At the close of the story, Poole and other humans land on Europa to start peaceful relations with the primitive native Europans. A statement is made that the monolith's makers will not determine humanity's fate until "the Last Days". A chronological continuation can be considered the short epilogue of the second book, 2010: Odyssey Two (1982), in which the action takes place 17,000 years later, in 20,001 CE (see more details).
=== Relationships and family === In December 2001, Newsom married legal commentator Kimberly Guilfoyle at Saint Ignatius Catholic Church. They separated in 2004 and jointly filed for divorce in January 2005, citing "difficulties due to their careers on opposite coasts". Their divorce was finalized on February 28, 2006, by which time Guilfoyle was expecting a child with Eric Villency. Guilfoyle gained prominence in 2011 via a Fox News chat show. She was later named senior advisor to Republican president Donald Trump, whom Newsom has extensively criticized, and was later engaged to Donald Trump Jr. In September 2006, Newsom, then 38, briefly dated 19-year-old Brittanie Mountz, a model and restaurant hostess. On January 31, 2007, Newsom's close friend, campaign manager, and former chief of staff Alex Tourk confronted him after learning from his wife, Ruby Rippey-Tourk, that she and Newsom had an affair in 2005, when she was Newsom's appointments secretary. Tourk immediately resigned. Newsom admitted to the affair the next day and apologized to the public, saying he was "deeply sorry" for his "personal lapse of judgment". In 2018, Rippey-Tourk said that she thought it wrong to associate Newsom's behavior with the #MeToo movement: "I was a subordinate, but I was also a free-thinking, 33-yr old adult married woman and mother. I do want to make sure that the #metoo movement is reserved for cases and situations that deserve it." Newsom began dating film director Jennifer Siebel in October 2006. He announced he would seek treatment for alcohol use disorder in February 2007.
== Personal life == Platt married Mary Camilla Bonsal Campbell on September 12, 1992, at the First Congregational Church in Kittery, Maine. They have three children. As of 1998, Platt had an open airline ticket when filming so he could return home frequently because his family did not accompany him to filming locations. In a 1999 interview, Platt explained that he had chosen to focus on film and television rather than theater because of his family. Platt has a home in North Haven, Maine.
Sources: en.wikipedia.org
It is a synthetic peptide that activates both the GIP and GLP-1 receptors, making it a dual agonist. Approved products are given by injection rather than by mouth. It is not a small molecule and does not belong to the older sulfonylurea or thiazolidinedione families.
Engaging two receptors recruits signaling pathways that only partly coincide. This can shift the magnitude of effects on insulin release, glucagon levels and appetite relative to selective agents. Whether the pairing delivers benefits beyond a simple sum of the two is still debated in the literature.
The proportional contribution of each receptor to observed clinical effects has not been fully separated. Long-term consequences of continuous dual stimulation are likewise unclear. Investigators continue to probe these points through laboratory and clinical work.
Reversed-phase liquid chromatography with ultraviolet detection is the usual approach, frequently combined with mass spectrometry for identity. Purity is reported as the area percentage of the main peak. Related impurities eluting near the main peak are usually summed and reported separately.